A real-world pharmacovigilance analysis of acute renal failure associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS). [PDF]
Wang S +5 more
europepmc +1 more source
Bibliometric analysis of sacubitril/valsartan in the management of chronic kidney disease (2013-2025). [PDF]
Liu P, He X, Luo X, Xie S, Li Y, Su B.
europepmc +1 more source
Long-term outcomes following sacubitril/valsartan therapy for chronic HFrEF: an Italian real-world multicentre study. [PDF]
Dattilo G +21 more
europepmc +1 more source
Simultaneous Determination of Glyphosate, Aminomethylphosphonic Acid, and Glufosinate in Green Coffee Beans by LC-MS/MS: Optimization, Validation, and Field Study. [PDF]
da Silva JCRM +6 more
europepmc +1 more source
Metabolism of 1-Aminocyclopropane-1-carboxylic Acid
M. Honma, T. Shimomura
semanticscholar +1 more source
A propensity score-matched retrospective study on sacubitril/valsartan use and 6-month readmission rates in patients with acute heart failure. [PDF]
Zhang L, Chen Q, Ren G.
europepmc +1 more source
The effectiveness and safety of sacubitril/valsartan in real-world dialysis patients with heart failure reduced ejection fraction. [PDF]
Tu KC, Weng YC, Liao CT, Wu JY.
europepmc +1 more source

